Abstract:Pulmonary thromboembolism (PTE) is a frequent cause of mortality in Kenya, but its characteristics are hardly reported in Subsaharan Africa. To describe the pattern of PTE among black Africans, in a Kenyan referral hospital. Retrospective study at Kenyatta National Hospital (KNH), Nairobi, Kenya. Records of patients seen between January 2005 and December 2009 were examined for mode of diagnosis, comorbidities, age, gender, treatment and outcome. Data were analyzed using SPSS version 15.0 and are presented in t… Show more
“…The male predominance this study is similar to the 55% reported by Kingue et al in Yaoundé-Cameroon [17], and different from that reported by that reported by Ogeng'o et al at an East African tertiary referral hospital [6]. The mean age of or patients was lower than the 60 ± 11.7 years reported by Aissa et al [7] in Tunisia, but higher that reported by Kingue et al [17] and Ogengo'o et al [6], who reported a mean age of 46 and 40.8 years respectively.…”
Section: Discussionsupporting
confidence: 54%
“…The mean age of or patients was lower than the 60 ± 11.7 years reported by Aissa et al [7] in Tunisia, but higher that reported by Kingue et al [17] and Ogengo'o et al [6], who reported a mean age of 46 and 40.8 years respectively. [3].…”
Section: Discussionmentioning
confidence: 51%
“…Autopsy reports showed a prevalence of 2.9% to 3.8% [3] [4], with an in-hospital incidence of 0.1% in Nigeria [5]. Data on the epidemiology of VTE are scarce in sub-Saharan Africa (SSA), with an in-hospital prevalence of 7% [6] [7] [8]. The yield for acute pulmonary embolism (PE) was 37.5% for suspected cases [9].…”
Background: Venous thromboembolism (VTE) is a major cause of morbidity and mortality worldwide. It is also the most common complication in hospitalized patients. Aims: To study the in-hospital prevalence of VTE, describe the socio-demographic characteristics of patients, determine the frequency of risk factors, describe the clinical presentations, and determine the short term outcome of VTE in hospitalized patients in a low-income tertiary hospital setting. Methods: We carried out a cross-sectional descriptive retrospective study over a period of 6 years and 4 months (January 2008 to April 2014) in the Douala General Hospital-Cameroon. Patients were cases of confirmed venous thromboembolic disease (VTE). Results: A total of 78 case files were retained for this study, giving an in-hospital prevalence of 4.4 per 1000 admissions.
“…The male predominance this study is similar to the 55% reported by Kingue et al in Yaoundé-Cameroon [17], and different from that reported by that reported by Ogeng'o et al at an East African tertiary referral hospital [6]. The mean age of or patients was lower than the 60 ± 11.7 years reported by Aissa et al [7] in Tunisia, but higher that reported by Kingue et al [17] and Ogengo'o et al [6], who reported a mean age of 46 and 40.8 years respectively.…”
Section: Discussionsupporting
confidence: 54%
“…The mean age of or patients was lower than the 60 ± 11.7 years reported by Aissa et al [7] in Tunisia, but higher that reported by Kingue et al [17] and Ogengo'o et al [6], who reported a mean age of 46 and 40.8 years respectively. [3].…”
Section: Discussionmentioning
confidence: 51%
“…Autopsy reports showed a prevalence of 2.9% to 3.8% [3] [4], with an in-hospital incidence of 0.1% in Nigeria [5]. Data on the epidemiology of VTE are scarce in sub-Saharan Africa (SSA), with an in-hospital prevalence of 7% [6] [7] [8]. The yield for acute pulmonary embolism (PE) was 37.5% for suspected cases [9].…”
Background: Venous thromboembolism (VTE) is a major cause of morbidity and mortality worldwide. It is also the most common complication in hospitalized patients. Aims: To study the in-hospital prevalence of VTE, describe the socio-demographic characteristics of patients, determine the frequency of risk factors, describe the clinical presentations, and determine the short term outcome of VTE in hospitalized patients in a low-income tertiary hospital setting. Methods: We carried out a cross-sectional descriptive retrospective study over a period of 6 years and 4 months (January 2008 to April 2014) in the Douala General Hospital-Cameroon. Patients were cases of confirmed venous thromboembolic disease (VTE). Results: A total of 78 case files were retained for this study, giving an in-hospital prevalence of 4.4 per 1000 admissions.
“…PTE diagnosis represented 0.31% of all hospitalizations during the 2-year studied period, an incidence rate similar to those reported in the United States (between 0.047-0.40%) [7]. Our data is limited to PE patients who were hospitalized, and PTE diagnosis could be more frequent in the emergency department, even though admittance rates reported in the US are around 86% [8].…”
Introduction. Pulmonary thromboembolism (PTE) represents a medical emergency and is the third most common cause of mortality after myocardial infarction and stroke. The purpose of this study was to describe the characteristics and management of patients with PTE admitted in a referral emergency hospital in Romania.Material and methods. We retrospectively reviewed all cases of PTE diagnosed in one of the largest emergency hospitals in Bucharest during a 2-year period (January 2014 -December 2016. Patients with acute PTE were identified by a database search of the diagnostic codes of all discharge diagnoses. Demographic, clinical and paraclinical tests data was retrieved from medical records.Results. 221 patients (48.87% male, mean age 61.76 years (range 21-94 years)) were diagnosed with PTE in our hospital (0.31% of all hospitalizations). Dyspnea was the most frequent symptom reported (78.9%), followed by pleuritic chest pain (23.9%) and unilateral leg pain (15.8%). Upon presentation, 12.6% of patients had high-risk PTE. Up to 72.8% of patients had at least one thrombotic risk factor, while cancer (14%) was the most frequent amongst them. The mean length of hospitalization was 10.3 ± 4.6 days. Unfractioned heparin (UFH) was the preferred anticoagulant during hospital stay (73.7%, p < 0.001). Vitamin K antagonists (AVK) were the preferred anticoagulant (71.7%, p < 0.001) after discharge, whereas non-antivitamin K oral anticoagulants (NOAC) were recommended in 26.3% of patients. Thrombolysis was used in 18 (8.4%) cases. Mortality was 0.9%.Younger patients more frequently associated thrombophilia or a previous thromboembolic event and clinical signs of DVT at presentation. Older patients associated more frequently a history of hospitalization for heart failure or atrial fibrillation during the previous 3 months and a history of cancer. The clinical presentation in older patients was more severe, with higher PESI scores (103.6 ± 33.4 vs. 55.5 ± 17.9, p<0.001) and a longer hospital stay (10.7 ± 4.7 vs. 9.2 ± 3.9, p = 0.03). The type of anticoagulant treatment did not differ depending on age.Conclusion. In our emergency hospital, PTE is a relatively rare cause of hospitalization; the rate is, however, comparable with other major hospitals. Dyspnea and pleuritic chest pain was the clinical presentation dyad. UFH was the preferred anticoagulant for in-hospital treatment while AVK was the preferred option for long term treatment and recurrence prophylaxis; however an increasing number of patients are prescribed NOAC. In older patients clinical severity was higher upon presentation, hospitalization duration was increased and cancer was more frequently associated. Younger patients associated more frequently a primary hypercoagulable state and recurrent thromboembolism. Mortality rate was low during hospitalization, comparable with that seen in other studied populations.
“…Pulmonary Emboli occur in 23 to 107 per 100,000 residents in France [4]. There are limited epidemiologic data in Africa, and the majority of authors estimate the hospital incidence to be 1.2% to 3.1% [5,6,7,8]. In 2014, thromboembolic diseases were the second cause of hospital admissions for cardiovascular diseases, after heart failure in the cardiology service in Burkina Faso.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.